Pharsight

CSL BEHRING patents facing oppositions

Top patents of CSL BEHRING facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3564267B1 17 Mar, 2021 Proteolytically cleavable fusion proteins with high molar specific activity NA 2
EP3226895B1 22 Jul, 2020 Pharmaceutical product with increased stability comprising immunoglobulins Dec, 2035 1
EP3383894B1 06 May, 2020 Improved media for the expression of recombinant vitamin k-dependent proteins NA 1
EP2538975B1 18 Sep, 2019 Immunoglobulin preparation and storage system for an immunoglobulin preparation NA 1
EP3006462B1 10 Apr, 2019 Method for purification of alpha-1-antitrypsin NA 1
EP2256135B1 13 Mar, 2019 Proteolytically cleavable fusion protein comprising a blood coagulation factor NA 1
EP2531218B1 12 Dec, 2018 Immunoglobulin preparation NA 1